BARRINGER TECHNOLOGIES INC
10QSB, 1997-04-30
TESTING LABORATORIES
Previous: BABSON D L BOND TRUST, 497, 1997-04-30
Next: BERGEN BRUNSWIG CORP, DEF 14A, 1997-04-30



         
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 10-QSB


  X      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
         EXCHANGE ACT OF 1934

For the quarterly period ended   March 31, 1997 

                                       OR

 __     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
        EXCHANGE ACT OF 1934

For the transition period from ____________________ to____________________

Commission file number    0-3207


                          Barringer Technologies Inc.
       _________________________________________________________________
       (EXACT NAME OF SMALL BUSINESS ISSUER AS SPECIFIED IN ITS CHARTER)
   
  Delaware                                             84-0720473 
(STATE OR OTHER JURISDICTION OF              (IRS EMPLOYER  IDENTIFICATION
INCORPORATION OR ORGANIZATION)                NUMBER)

                219 South Street, Murray Hill, New Jersey 07974
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

                                (908) 665-8200
                           (Issuer's telephone number)

               219 South Street, New Providence, New Jersey 07974
             (FORMER NAME, FORMER ADDRESS AND FORMER FISCAL YEAR, IF
                           CHANGED SINCE LAST REPORT)

     Check whether the registrant (1) filed all reports  required to be filed by
Section 13 or 15(d) of the Exchange  Act during the  preceding 12 months (or for
such shorter period that the registrant was required to file such reports),  and
(2) has been subject to such filing requirements for the past 90 days.
Yes    X          No          
    --------         -------

     State the number of shares  outstanding of each of the issuer's  classes of
common equity, as of the latest  practicable date:

     Common  stock,  $0.01  par  value -  outstanding  as of  April  22,  1997 -
5,437,893 shares

        Transitional Small Business Disclosure Format (check one):
Yes    ; No X


<PAGE>


                  BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES

                                      INDEX
                                                                       Page No.

Part I  o  Financial Information

          - Consolidated Balance Sheets as of March 31, 1997
            (unaudited) and December 31, 1996                               4

          - Consolidated Statements of Income (unaudited)
            for the three months ended March 31, 1997 and 1996              6

          - Consolidated Statements of Cash Flows (unaudited)
            for the three months ended March 31, 1997 and 1996              7

          - Notes to Consolidated Financial Statements                      8

          - Management's Discussion and Analysis of Financial
            Condition and Results of Operations                             9

Part II o Other Information                                                13

Signatures                                                                 14

Exhibits                                                                   15



<PAGE>


                  BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS








ASSETS                                          March 31,              Dec. 31,
                                                  1997                  1996
                                              (unaudited)

Current assets:
 Cash and cash equivalents                    $3,050,000            $5,276,000
 Marketable securities                         4,876,000             4,328,000
 Trade receivables, less allowances of
     $62,000 and $63,000                       5,070,000             3,521,000
 Inventories                                   2,650,000             2,270,000
 Prepaid expenses and other                      238,000               498,000
 Deferred tax asset                              856,000               731,000
                                              -----------          -----------
     Total current assets                     16,740,000            16,624,000

Property and equipment                           953,000               595,000

Other assets                                      79,000               104,000
                                              -----------           ----------

     Total assets                             $17,772,000           $17,323,000
                                              ===========           ===========




See notes to consolidated financial statements.

<PAGE>


                  BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS


LIABILITIES AND EQUITY                              March 31,      Dec. 31,
                                                      1997             1996
                                                  (unaudited)
Current liabilities:
 Bank indebtedness and other notes               $     -            $174,000
 Accounts payable                                   887,000        1,009,000
 Accrued liabilities                                523,000          648,000
 Accrued payroll and related taxes                  432,000          522,000
                                                 -----------       ---------
    Total current liabilities                      1,842,000       2,353,000

Other non-current liabilities                        118,000         117,000
                                                  -----------      ---------

     Total liabilities                             1,960,000       2,470,000
                                                  -----------      ---------

Shareholders' equity:
   Preferred stock, $2.00 par value, 4,000,000
     shares authorized:
     270,000 shares designated class A convertible
       preferred stock, 58,206 and 60,165 shares
       outstanding less discount of $45,000 and
       $47,000, respectively                          71,000          74,000
     730,000 shares designated class B convertible
       preferred stock, 22,500 and 122,500 shares
       outstanding, respectively                      45,000         245,000
   Common stock, $.01 par value, 7,000,000 shares
     authorized, 5,433,000 and 5,357,000 shares
     outstanding, respectively                        54,000          54,000
 Additional paid-in capital                       29,821,000      29,430,000
 Accumulated deficit                             (13,677,000)    (14,522,000)
 Foreign currency translation                       (489,000)       (415,000)
                                                 ------------    ------------
                                                  15,825,000      14,866,000
 Less: common stock in treasury at cost, 31,000
   shares                                            (13,000)        (13,000)
                                                 ------------    ------------
    Total shareholders' equity                    15,812,000      14,853,000
                                                 ------------    ------------
Total liabilities and equity                     $17,772,000     $17,323,000
                                                 ============    ============




See notes to consolidated financial statements.


<PAGE>


                  BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
                        CONSOLIDATED STATEMENT OF INCOME
                      FOR THE THREE MONTHS ENDED MARCH 31,
                                   (UNAUDITED)

                                                       1997           1996
                                                   ----------     ----------
Revenues from operations                           $3,622,000     $2,354,000
Cost of sales                                       1,461,000      1,236,000
                                                   ----------     ----------
                                                    2,161,000      1,118,000
                                                   ----------     ----------
Operating expenses:
        Selling, general and administrative         1,295,000        809,000
        Product development                           175,000         17,000
                                                   ----------     ----------
                                                    1,470,000        826,000
                                                   ----------     ----------

             Operating income                         691,000        292,000
                                                   ----------     ----------
Other income (expense):
        Interest income                                97,000           -
        Interest expense                               (2,000)       (66,000)
        (Loss) on unconsolidated subsidiary               -          (22,000)
        Other, net                                    (16,000)       (15,000)
                                                   ----------     ----------
                                                       79,000       (103,000)
                                                   ----------     ----------
             Income before income tax 
             provision (benefit)                      770,000        189,000
Income tax provision (benefit) (note 2)               (75,000)          -
                                                   ----------     ----------
             Net income for the period                845,000        189,000
Preferred stock dividend requirements                  (3,000)       (12,000)
                                                   ----------     ----------
             Net income attributable to common       $842,000     $  177,000
             shareholders
                                                   ==========     ==========

Per share data (note 3):
   Primary earnings per share                      $     0.14     $     0.05
                                                   ==========     ==========
   Fully diluted earnings per share                $     0.14     $     0.05
                                                   ==========     ==========

Weighted average common and 
common equivalent shares outstanding:
   Primary                                          6,080,000      3,479,000
                                                   ==========     ==========
   Fully diluted                                    6,109,000      3,479,000
                                                   ==========     ==========


See notes to consolidated financial statements.

<PAGE>


                  BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                          THREE MONTHS ENDED MARCH 31,
                                   (UNAUDITED)

                                                          1997         1996
                                                       ---------    ----------
OPERATING ACTIVITIES
Net Income                                              $845,000      $189,000
Items not affecting cash:
        Depreciation/amortization                         40,000        54,000
        Loss from unconsolidated Investment                 -           22,000
        Deferred tax (benefit)                         (125,000)          -
        Other                                           (54,000)        95,000
(Increase) in non-cash working capital balances      (2,005,000)      (815,000)
                                                    ------------     ----------
               Cash (used in) operating activities   (1,299,000)      (455,000)
                                                    ------------     ----------
INVESTING ACTIVITIES
Purchase of equipment and other                        (373,000)       (26,000)
Purchase of marketable securities                      (548,000)          -
                                                    ------------     ----------
               Cash (used in) investing activities     (921,000)       (26,000)
                                                    ------------     ----------
FINANCING ACTIVITIES
Increase (reduction) in bank debt and
other                                                  (174,000)        487,000
Proceeds on issuance of securities                      168,000           -
                                                     -----------     ----------
             Cash provided by (used in) financing        (6,000)        487,000
             activities
                                                    ------------     ----------
Increase (decrease) in cash                          (2,226,000)          6,000
Cash at beginning of period                           5,276,000          43,000
                                                    ------------     ----------
Cash at end of period                                 $3,050,000        $49,000
                                                    ============    ===========
CHANGES IN COMPONENTS OF NON-CASH
WORKING CAPITAL BALANCES RELATED TO
CONTINUING OPERATIONS

Receivables                                         $(1,548,000)     $(806,000)
Inventory                                              (380,000)       (34,000)
Other current assets                                     260,000       (14,000)
Other assets                                                   -        27,000
Accounts payable and accrued expenses                  (337,000)        12,000
                                                    -------------   -----------
(Increase) in non-cash working capital balances     $(2,005,000)     $(815,000)
                                                    =============   ===========

Cash paid during the period for interest                  $2,000       $53,000
                                                    =============   ===========
Cash paid during the period for income taxes            $150,000            $0
                                                    =============   ===========

See notes to consolidated financial statements.


<PAGE>


                  BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


1.  In  the  opinion  of  the  Company,  the  unaudited  consolidated  financial
statements  contain  all  adjustments   (consisting  of  only  normal  recurring
accruals) necessary to present fairly the consolidated financial position of the
Company  as of March 31,  1997 and the  results of its  operations  and its cash
flows for the three  months  ended  March 31, 1997 and 1996,  respectively.  The
accounting  policies  followed  by the  Company  are set  forth in the  Notes to
Consolidated   Financial  Statements  in  the  audited  consolidated   financial
statements  of  Barringer  Technologies  Inc. and  Subsidiaries  included in its
Annual Report on Form 10-KSB for the year ended  December 31, 1996.  This report
should be read in  conjunction  therewith.  The  results of  operations  for the
interim periods are not necessarily indicative of the results to be expected for
any other interim period or for the full year.

2.     As a result of the  Company's  historical  trend of losses,  a valuation
allowance has been  provided for a substantial  portion of the U.S. and Canadian
deferred  tax assets.  The  valuation  allowance  was  reduced by  approximately
$125,000 for the three months ended March 31, 1997, which created a deferred tax
benefit of an equivalent amount.  Based on historical results and estimated 1997
earnings,  which includes earnings from certain contracts,  as well as available
tax planning  strategies,  management  considers  realization  of the unreserved
deferred tax asset more likely than not. Additional  reductions to the valuation
allowance  will be recorded  when, in the opinion of  management,  the Company's
ability to generate taxable income  sufficient to reduce  additional  amounts of
the valuation allowance is considered more likely than not.

3.     Net income per share is computed by dividing net income,  less preferred
stock dividends,  by the weighted average number of common and common equivalent
shares  outstanding  during the period.  Common equivalent shares consist of the
dilutive effect, if any, of unissued shares under options and warrants, computed
using the  treasury  stock  method  (using the average  stock prices for primary
basis and the higher of average or  period-end  stock  prices for fully  diluted
basis).  Fully diluted  income per share is computed  assuming the conversion of
convertible  preferred  stock  at the  beginning  of the  period  or the date of
issuance, whichever is later.

4. On February 28, 1997, the Company's Board of Directors  granted options to 13
officers,  directors  and  key  employees,  to  acquire  135,500  shares  of the
Company's  common  stock at $9.375  per  share,  which was the fair value of the
stock on the date of grant. These grants are subject to shareholder approval.


<PAGE>


                  BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS


Quarter ended March 31, 1997 Compared To Quarter ended March 31, 1996

The following  table presents  certain  income  statement  items  expressed as a
percentage of total revenue for the three month periods ended March 31, 1997 and
1996. Percentage of Total Revenue


                                                  Three months ended March 31,
                                                        1997            1996
                                                      -------         -------
  Statement of operations data: (1)
    Revenues from operations........................   100.0           100.0
    Cost of revenues................................    40.3            52.5
    Gross profit....................................    59.7            47.5
    Selling, general and administrative expenses        35.8            34.4
    Product development..............................    4.8             0.7
    Operating income ................................   19.1            12.4
    Other income (expense), net.....................     2.2           (4.4)
    Income tax benefit .............................     2.1               -
    Net income ......................................   23.4             8.0
    Preferred stock dividend requirements...........   (0.1)           (0.5)
    Net income attributable to common                   23.3             7.5
       stockholders.................................
(1) Columns may not foot due to rounding.

     Revenues from  operations  increased by $1,268,000,  or 53.9%, in the three
months ended March 31, 1997,  as compared to the same period in 1996.  Net sales
of the IONSCAN(R) and related products increased by approximately $1,763,000, or
104.4%,  due to an equal percentage  increase in the number of units sold during
the first quarter of 1997 as compared to the same quarter in 1996.  The increase
in IONSCAN(R)  sales was due to an approximate 50% increase in unit sales to the
aviation security market. Other non-IONSCAN(R)  revenues decreased $495,000,  or
75%, in the three months ended March 31, 1997 as compared to the same quarter in
1996 primarily due to a drop in revenues from contract research and development.
During the first  quarter of 1997,  the Federal  Aviation  Administration  (FAA)
awarded the Company a $700,000  grant for the first phase of the  development of
an automated luggage explosives  detection system. The Company  anticipates that
substantially  all of the  revenues  under the first phase of this grant will be
recognized in 1997.

     Gross profit as a percentage  of sales for the three months ended March 31,
increased to 59.7% from 47.5% in the same quarter in 1996. The  improvement  was
primarily  attributable to higher margins on international  sales,  coupled with
larger,  more efficient  production runs of the IONSCAN(R) and related products.
Increased  production  levels  have  resulted  in  lower  material  costs,  more
efficient direct labor costs and less overhead cost absorbed per unit produced.

     Selling,  general and  administrative  expenses  increased by approximately
$486,000,  or 60.1%,  for the three months ended March 31, 1997,  as compared to

<PAGE>

the same quarter in 1996.  As a percentage  of  revenues,  selling,  general and
administrative  expenses increased to 35.8% for the three months ended March 31,
1997 as  compared  to 34.4%  for the same  quarter  in  1996.  Selling  expenses
increased  by $255,000,  or 49.7%,  for the three months ended March 31, 1997 as
compared to the same quarter in 1996, as a result of increased sales commissions
and increased  costs  associated  with an expanding  sales  effort.  General and
administrative  expenses  increased by $231,000 for the three months ended March
31,  1997 as  compared  to the same  quarter in 1996,  primarily  as a result of
increased  payroll  costs  and  other  expenses  associated  with  building  the
necessary infrastructure to handle the growth of the business.

     Product development expenses increased by approximately  $158,000, or 929%,
for the three months  ended March 31,  1997,  as compared to the same quarter in
1996.  The level of product  development  engaged in by the  Company at any time
has primarily  been a function of the resources,  both financial and personnel,
that were  available.  The Company  expects to devote more  resources to product
development and such expenses are expected to increase  significantly during the
remainder of 1997, as compared to 1996.

     In the three  months ended March 31, 1997,  the Company  earned  investment
income of $97,000.

     In the three months ended March 31, 1997, the Company had interest  expense
of $2,000 as compared to $66,000 for the same quarter in 1996. Substantially all
of the Company's  debt was repaid in late 1996 with a portion of the proceeds of
the public offering completed in late 1996.

     In the three months  ended March 31, 1996,  the Company had income from its
investment in an unconsolidated subsidiary, which it disposed of in its entirety
in December 1996.

     For the three  months  ended  March 31,  1997,  the  Company  had a net tax
benefit of $75,000  primarily  due to a reduction in the deferred tax  valuation
allowance as a result of changes in management's estimates of the utilization of
both US and  Canadian  tax  loss  carryforwards  caused  primarily  by  improved
operating results in Canada and the United States.  Management  anticipates that
further deferred tax benefits will be recognized in 1997.

Capital Resources and Liquidity

     Although the Company  generated net income of $845,000 for the three months
ended March 31, 1997, the Company used  $1,299,000 of cash in operations  during
such period as a result of the need for working capital to support higher levels
of accounts  receivable and  inventory.  During the three months ended March 31,
1997,  accounts receivable  increased by $1,549,000 to $5,070,000.  The increase
was primarily the result of the Company having provided  extended  payment terms
for sales made in the fourth quarter of 1996.  Additionally,  essentially all of
the sales for the quarter ended March 31, 1997,  were  transacted in March 1997.
Inventories  increased by $380,000 to  $2,650,000 at March 31, 1997, as a result
of  increased  purchases  of  materials  in  anticipation  of a 50%  increase in
production expected to occur in the second quarter of 1997 compared to the first
quarter  of 1997.  However,  as a result of the net  proceeds  of  approximately
$10,400,000 from the Company's recent public offering and the Company's improved
profitability,


<PAGE>

management  believes  that the  Company  will have  sufficient  cash to fund its
working capital requirements and to execute its growth plans through 1998.

     The  Company's  capital  expenditures  for the three months ended March 31,
1997 aggregated approximately $373,000. Such expenditures consisted primarily of
software  upgrades  to  various  manufacturing   information  systems,  computer
hardware  modernization  relating  to  the  Company's  network  system  and  the
acquisition of additional equipment.  The Company anticipates that total capital
expenditures  will  be  approximately   $200,000  for  the  remainder  of  1997,
substantially all of which will relate to equipment.

     The Company has  substantial  tax loss and  research  and  development  tax
credit carryforwards to offset future tax liabilities in the United States.

Inflation

     Inflation  was not a material  factor in either the sales or the  operating
expenses of the Company during the periods presented herein.

Recent Pronouncements of the Financial Accounting Standards Board

     In February 1997, the Financial Accounting Standards Board issued statement
of Financial  Accounting  Standards  No. 128,  "Earnings  Per Share" (FASB 128),
which  establishes  standards for computing and  presenting  earnings per share.
FASB 128  replaces  the  presentation  of primary  earnings  per share and fully
diluted  earnings per share with basic  earnings per share and diluted  earnings
per share,  respectively.  Basic  earnings  per share  excludes  dilution and is
computed by dividing  income  available to common  stockholders  by the weighted
average number of common shares outstanding for the period. Diluted earnings per
share is computed similarly to fully diluted earnings per share. The standard is
effective for financial  statements  for periods ending after December 15, 1997,
with earlier application not permitted.

     Basic and diluted  earnings per share using this  standard  would have been
$0.16 and $0.14,  respectively  for the three months  ended March 31, 1997,  and
$0.05 and $0.05, respectively, for the three months ended March 31, 1996.

Disclosure Regarding Forward Looking Statements

     This Form 10-QSB contains forward-looking  statements within the meaning of
Section 27A of the  Securities  Act of 1933, as amended,  and Section 21E of the
Securities Exchange Act of 1934, as amended.  Such statements  include,  but are
not limited to, the  anticipated  development and growth of markets for products
of the Company, the anticipated growth in the demand for the Company's products,
the Company's  opportunities to increase sales the development of new IONSCAN(R)
products,  the  probability  of  the  Company's  success  in  the  sales  of its
IONSCAN(R) products and liquidity and capital requirements.

     Forward-looking   statements   are   inherently   subject   to  risks   and
uncertainties,  many of which can not be  predicted  with  accuracy  and some of


<PAGE>


which might not even be anticipated. Future events and actual results, financial
and otherwise,  could differ  materially from those set forth in or contemplated
by  the  forward-looking   statements  herein.   Important  factors  that  could
contribute to such differences  include, but are not limited to, the development
and growth of markets for the Company's  products,  the Company's  dependence on
and the effect of governmental regulations on demand for the Company's products,
the impact of both foreign and domestic governmental budgeting decisions and the
timing  of  governmental  expenditures,  the  reliance  of  the  Company  on its
IONSCAN(R)  products,  and the  dependence  of the  Company  on its  ability  to
successfully  develop  and  market  new  product  applications,  the  effects of
competition,  and the effect of general economic and market conditions,  as well
as conditions  prevailing in the markets for the Company's products.  Certain of
the factors  summarized  above are  described  in more  detail in the  Company's
Registration  Statement on Form SB-2 (File no. 333-13703) and the Company's 1996
Annual Report on Form 10-KSB and reference is hereby made thereto for additional
information with respect to the matters referenced above.



<PAGE>


                  BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES

                                     PART II
                                OTHER INFORMATION




ITEM 6.  Exhibits and Reports on Form 8-K

(a) Exhibits

   3.1A  The Company's Certificate of Incorporation, as amended is Incorporated
         by reference  to  the identically numbered exhibit to the Registrant's
         Registration Statement on Form S-1, File No. 33-31626.
 
   3.2A  By-laws of the Company is Incorporated by reference to the identically
         numbered exhibit to the Registrant's Form 8-K, filed on December 27, 
         1995, file No. 0-3207.

   11    Earnings per share exhibit

   27    Financial Data Schedule


(b) Reports on Form 8-K

          None

<PAGE>



                  BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES


                                   SIGNATURES


In accordance with the requirements of the Exchange Act , the Registrant  caused
this  report to be  signed on its  behalf  by the  undersigned,  thereunto  duly
authorized.


                      BARRINGER TECHNOLOGIES INC.
                      (Registrant)

                      /s/ Stanley S. Binder
                      Stanley S. Binder
                      President,
                      
                      /s/ Richard S. Rosenfeld
                      Richard S. Rosenfeld, Chief Financial Officer
                      (Principal Accounting Officer)


                      Date: April 28, 1997


<PAGE>


                           BARRINGER TECHNOLOGIES INC.

                                INDEX TO EXHIBITS


             Exhibit Number

             11  Earnings Per Share

             27  Financial Data Schedule



                                                                     EXHIBIT 11
                   BARRINGER TECHNOLOGIES INC AND SUBSIDIARIES
                                EARNING PER SHARE


                                 PRIMARY                      FULLY DILUTED
                      ----------------------------- ----------------------------
                       Three months ended March 31, Three months ended March 31,
                      ----------------------------- --------------------------
                             1997          1996            1997          1996
                             ----          ----           ----           ----
Net Income                $ 845,000    $ 189,000       $ 845,000    $   189,000
Preferred dividend
requirements                 (3,000)     (12,000)                      (12,000)
                          -----------------------       -----------------------
Net income to common 
stockholders
                          $  842,000   $ 177,000       $ 845,000      $ 177,000
                          ======================       ========================

Weighted average shares
outstanding
                           5,392,000   3,479,000       5,392,000      3,479,000
Assumed conversion of
preferred stock
                                n/a          n/a          29,000            n/a
Assumed exercise of
outstanding options
and warrants(treasury
stock method)                688,000         n/a        688,000             n/a
                           ----------------------     -------------------------
Revised share basis        6,080,000    3,479,000     6,109,000       3,479,000
                          =======================     =========================

Earnings per common share $    0.14    $    0.05      $    0.14  $         0.05
                          ======================      =========================




<TABLE> <S> <C>


<ARTICLE>                     5

<CIK>                         0000010119
<NAME>                        Barringer Technologies, Inc.
<MULTIPLIER>                                   1,000
<CURRENCY>                                     0
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-END>                                   MAR-31-1997
<EXCHANGE-RATE>                                1
<CASH>                                         3,050
<SECURITIES>                                   4,876
<RECEIVABLES>                                  5,132
<ALLOWANCES>                                   62
<INVENTORY>                                    2,650
<CURRENT-ASSETS>                               16,690
<PP&E>                                         2,249
<DEPRECIATION>                                 1,296
<TOTAL-ASSETS>                                 17,722
<CURRENT-LIABILITIES>                          1,792
<BONDS>                                        0
                          0
                                    116
<COMMON>                                       54
<OTHER-SE>                                     15,642
<TOTAL-LIABILITY-AND-EQUITY>                   17,722
<SALES>                                        3,622
<TOTAL-REVENUES>                               3,622
<CGS>                                          1,461
<TOTAL-COSTS>                                  1,470
<OTHER-EXPENSES>                               (81)
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             2
<INCOME-PRETAX>                                770
<INCOME-TAX>                                   (75)
<INCOME-CONTINUING>                            845
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   845
<EPS-PRIMARY>                                  0.14
<EPS-DILUTED>                                  0.14
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission